Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$114.22 - $140.1 $319,816 - $392,280
2,800 New
2,800 $388,000
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $855,501 - $1.06 Million
11,205 Added 59.24%
30,118 $2.43 Million
Q2 2022

Aug 05, 2022

BUY
$67.99 - $132.89 $977,220 - $1.91 Million
14,373 Added 316.59%
18,913 $1.41 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $309,899 - $428,878
-3,294 Reduced 42.05%
4,540 $2.32 Million
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $204,025 - $255,790
1,571 Added 25.08%
7,834 $4.21 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $202,322 - $271,469
1,896 Added 43.42%
6,263 $3.43 Million
Q2 2021

Aug 12, 2021

SELL
$80.99 - $107.93 $91,599 - $122,068
-1,131 Reduced 20.57%
4,367 $1.87 Million
Q1 2021

May 13, 2021

BUY
$84.79 - $104.74 $21,367 - $26,394
252 Added 4.8%
5,498 $1.98 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $21,450 - $28,737
275 Added 5.53%
5,246 $1.94 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $55,682 - $65,849
583 Added 13.29%
4,971 $2.05 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $275,039 - $462,231
4,388 New
4,388 $1.78 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.